{
  "ptid_time": "011_S_0022_2006-04-20",
  "img_path": "/data/qiuhui/data/adni/images/011_S_0022/2006-04-20/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 5,737 mm³, 80.9% below the reference mean. With a Z-score of -1.92 (2.7th percentile), this represents moderate atrophy; hippocampal volume measures 6,486 mm³, 19.2% below the reference mean. With a Z-score of -1.92 (2.8th percentile), this represents moderate atrophy; whole brain volume measures 888,846 mm³, 21.7% below the reference mean. With a Z-score of -3.07 (0.1th percentile), this represents profound atrophy; entorhinal cortex volume measures 2,563 mm³, 39.9% below the reference mean. With a Z-score of -2.76 (0.3th percentile), this represents significant atrophy; fusiform gyrus volume measures 16,523 mm³, 17.0% below the reference mean. With a Z-score of -1.41 (7.9th percentile), this represents mild atrophy; middle temporal gyrus volume measures 15,435 mm³, 31.1% below the reference mean. With a Z-score of -2.56 (0.5th percentile), this represents significant atrophy. ",
  "text_data": "Age is 63.7 years. Gender is Male. Education: 17 years. MMSE: 28.0. APOEε4 alleles: 1.0. ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows significant atrophy in multiple brain regions, particularly the whole brain, entorhinal cortex, and middle temporal gyrus, which are strongly associated with Alzheimer's pathology. However, the MMSE score of 28 is within the normal range, suggesting preserved cognitive function despite structural changes.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (due to structural atrophy with intact cognition)  \n**Confidence:** **Medium** (high confidence in atrophy, but cognitive scores complicate the diagnosis)  \n\n*Note: The discrepancy between imaging and cognitive performance could indicate preclinical Alzheimer's or a resilient cognitive reserve. Follow-up cognitive testing (e.g., MoCA, neuropsychological battery) and biomarker assessment (e.g., CSF Aβ/tau, amyloid PET) would strengthen diagnostic certainty.*",
  "timestamp": "2025-07-25T22:40:50.622327"
}